Literature DB >> 22698402

Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells.

Teresa Davoli1, Titia de Lange.   

Abstract

Human cancers with a subtetraploid karyotype are thought to originate from tetraploid precursors, but the cause of tetraploidization is unknown. We previously documented endoreduplication in mouse cells with persistent telomere dysfunction or genome-wide DNA damage. We now report that endoreduplication and mitotic failure occur during telomere crisis in human fibroblasts and mammary epithelial cells and document the role of p53 and Rb in repressing tetraploidization. Using an inducible system to generate transient telomere damage, we show that telomere-driven tetraploidization enhances the tumorigenic transformation of mouse cells. Similar to human solid cancers, the resulting tumors evolved subtetraploid karyotypes. These data establish that telomere-driven tetraploidization is induced by critically short telomeres and has the potential to promote tumorigenesis in early cancerous lesions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22698402      PMCID: PMC3376354          DOI: 10.1016/j.ccr.2012.03.044

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  47 in total

1.  Senescence induced by altered telomere state, not telomere loss.

Authors:  Jan Karlseder; Agata Smogorzewska; Titia de Lange
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

2.  A DNA damage checkpoint response in telomere-initiated senescence.

Authors:  Fabrizio d'Adda di Fagagna; Philip M Reaper; Lorena Clay-Farrace; Heike Fiegler; Philippa Carr; Thomas Von Zglinicki; Gabriele Saretzki; Nigel P Carter; Stephen P Jackson
Journal:  Nature       Date:  2003-11-05       Impact factor: 49.962

Review 3.  G1 tetraploidy checkpoint and the suppression of tumorigenesis.

Authors:  Robert L Margolis; Olivier D Lohez; Paul R Andreassen
Journal:  J Cell Biochem       Date:  2003-03-01       Impact factor: 4.429

4.  Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.

Authors:  N Tjarda van Heek; Alan K Meeker; Scott E Kern; Charles J Yeo; Keith D Lillemoe; John L Cameron; G Johan A Offerhaus; Jessica L Hicks; Robb E Wilentz; Michael G Goggins; Angelo M De Marzo; Ralph H Hruban; Anirban Maitra
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.

Authors:  Alan K Meeker; Jessica L Hicks; Elizabeth A Platz; Gerrun E March; Christina J Bennett; Michael J Delannoy; Angelo M De Marzo
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes.

Authors:  S R Romanov; B K Kozakiewicz; C R Holst; M R Stampfer; L M Haupt; T D Tlsty
Journal:  Nature       Date:  2001-02-01       Impact factor: 49.962

7.  Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.

Authors:  S E Artandi; S Chang; S L Lee; S Alson; G J Gottlieb; L Chin; R A DePinho
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

8.  Different telomere damage signaling pathways in human and mouse cells.

Authors:  Agata Smogorzewska; Titia de Lange
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

Review 9.  Molecular evolutionary patterns in breast cancer.

Authors:  Stanley E Shackney; Jan F Silverman
Journal:  Adv Anat Pathol       Date:  2003-09       Impact factor: 3.875

10.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).

Authors:  Utz Herbig; Wendy A Jobling; Benjamin P C Chen; David J Chen; John M Sedivy
Journal:  Mol Cell       Date:  2004-05-21       Impact factor: 17.970

View more
  102 in total

Review 1.  Polyteny: still a giant player in chromosome research.

Authors:  Benjamin M Stormo; Donald T Fox
Journal:  Chromosome Res       Date:  2017-08-04       Impact factor: 5.239

Review 2.  Understanding telomere diseases through analysis of patient-derived iPS cells.

Authors:  Luis F Z Batista; Steven E Artandi
Journal:  Curr Opin Genet Dev       Date:  2013-08-28       Impact factor: 5.578

3.  Proliferation of Double-Strand Break-Resistant Polyploid Cells Requires Drosophila FANCD2.

Authors:  Heidi S Bretscher; Donald T Fox
Journal:  Dev Cell       Date:  2016-06-06       Impact factor: 12.270

Review 4.  Senescence from G2 arrest, revisited.

Authors:  Véronique Gire; Vjekoslav Dulic
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 5.  Endoreplication and polyploidy: insights into development and disease.

Authors:  Donald T Fox; Robert J Duronio
Journal:  Development       Date:  2013-01-01       Impact factor: 6.868

Review 6.  A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Authors:  Maurizio Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

7.  Induction of endocycles represses apoptosis independently of differentiation and predisposes cells to genome instability.

Authors:  Christiane Hassel; Bingqing Zhang; Michael Dixon; Brian R Calvi
Journal:  Development       Date:  2013-11-27       Impact factor: 6.868

Review 8.  Polyploidy in liver development, homeostasis and disease.

Authors:  Romain Donne; Maëva Saroul-Aïnama; Pierre Cordier; Séverine Celton-Morizur; Chantal Desdouets
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-02       Impact factor: 46.802

9.  Molecular Cytogenetic Characterization Identified the Murine B-Cell Lymphoma Cell Line A-20 as a Model for Sporadic Burkitt's Lymphoma.

Authors:  Karolina Guja; Thomas Liehr; Martina Rincic; Nadezda Kosyakova; Shaymaa S Hussein Azawi
Journal:  J Histochem Cytochem       Date:  2017-09-13       Impact factor: 2.479

10.  Generation and Purification of Tetraploid Cells.

Authors:  Elizabeth M Shenk; Neil J Ganem
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.